Cannabidiol Side Effects: Common, Severe, Long Term
Data:
1 Dicembre 2023
CBD may produce favorable outcomes for people attempting to lower their blood pressure. Multiple recent studies have shown CBD’s effectiveness in reducing blood pressure in those with hypertension. There is conflicting evidence to support the use of cannabinoids to treat sleep disorders. CBD might help treat anxiety disorders, although there have not been many trials to look at CBD’s anxiety-relieving effects in humans. In June 2018, the FDA approved a CBD oral solution called Epidiolex. Epidiolex is a prescription drug, not an over-the-counter (OTC) product.
- Self-selection bias is increased by the significant patient interest in medical cannabis as these patients must be motivated to access the non-traditional medication system.
- AEs occurred more frequently in the CBD than the placebo group, with somnolence (36% vs 10%) being the most common AE.
- In addition, ABCC1 transporter was inhibited in human ovarian carcinoma cells with a CBD IC50 of 128.3 μM [110].
- Additionally, there was an important loss to follow-up at the 6-month visit (FUP2) due to missed appointment and cost barriers, limiting the power of the findings.
How much CBD should you use?
Additionally, CBD diminished the Bezold-Jarisch reflex induced by 5-HT3 receptor activation [52]. CBD can also modify the baroreflex response after central (into the bed nucleus of the stria terminalis, BNST) administration. Thus, it exhibited a facilitatory influence on the reflex bradycardiac response to blood pressure increases via 5-HT1A receptors activation [47]. The endocannabinoid system does not seem to be significant for cardiovascular regulation under physiological is cannabidiol addictive conditions, as both FAAH inhibitors and CB1 receptor antagonists do not significantly affect blood pressure in normotensive animals [19,20]. This situation changes in pathological conditions when activation of the endocannabinoid system is often observed [20,27]. Such activation may be protective or detrimental, e.g., endocannabinoid-induced vasorelaxation is beneficial in arterial hypertension, but deleterious in septic shock or portal hypertension [20,27].
Medications changed by the liver (Cytochrome P450 2C9 (CYP2C substrates) interacts with CANNABIDIOL (CBD)
In a 2017, randomized, double-blind, placebo-controlled CBD trial on Dravet’s syndrome, 120 children received 20 mg/kg/day oral CBD or placebo for 14 weeks, in conjunction with their standard treatment (1 to 5 antiepileptic drugs) [71]. AEs occurred more frequently in the CBD than the placebo group, with somnolence (36% vs 10%) being the most common AE. The greatest success for CBD treatment is the reduction in seizures in children with refractive epilepsy.
Medications changed by the liver (Cytochrome P450 1A1 (CYP1A substrates) interacts with CANNABIDIOL (CBD)
It was concluded that CBD did not provide neuroprotection during early global hypoxia-ischemia [63]. In vitro CBD toxicity was identified in Sprague Dawley rats’ oligodendrocytes, the cells responsible for CNS white matter myelination [59]. Following incubation with 100 nM-10 μM CBD for min, a concentration-dependent decrease in oligodendrocyte viability was observed. The mechanism appeared to be through increases in intracellular Ca2+. If there was no extracellular Ca2+, CBD-induced cell death was reduced at 1 µM by 50.4%±18%. Furthermore, the disruption of mitochondrial membrane potential (MMP), and ROS production were reduced.
Therefore, some authors suggest that the proposed endothelial cannabinoid receptor may be GPR18. However, not all experimental observations confirm it explicitly [73]. In addition, GPR18-independent activation of high-conductance Ca2+-activated K+ (BKCa) channels might contribute to vasodilatory action of Abn-CBD [157]. Abn-CBD can also lower blood pressure after intra-RVLM administration via GPR18 activation which leads to sympathoinhibition [158]. Moreover, this compound is an agonist of GPR55, however this receptor does not mediate vasorelaxant response to Abn-CBD [150].
CBD-rich products in Canada
CBD Oil Benefits
Effects of Abnormal-Cannabidiol on the Cardiovascular System
What Happens if I Take Too Much CBD?
Ultimo aggiornamento
26 Settembre 2024, 16:42